Press release
Becker Muscular Dystrophy Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight | Epirium Bio, Immuno Forge, Italfarmaco, Santhera Pharmaceuticals, Edgewise Th
"Becker Muscular Dystrophy Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Becker Muscular Dystrophy Market.
The Becker Muscular Dystrophy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Becker Muscular Dystrophy Pipeline Report: https://www.delveinsight.com/sample-request/becker-muscular-dystrophy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Becker Muscular Dystrophy treatment therapies with a considerable amount of success over the years. Becker Muscular Dystrophy Key players such as - Epirium Bio, Immuno Forge, Italfarmaco, Santhera Pharmaceuticals, Edgewise Therapeutics, and others, are developing therapies for the Becker Muscular Dystrophy treatment
• Becker Muscular Dystrophy Emerging therapies such as - EPM-01, PF1801, Givinostat, Vamorolone, EDG 5506, and others are expected to have a significant impact on the Becker Muscular Dystrophy market in the coming years.
• In April 2024, Edgewise Therapeutics, a biotech firm in the US, has announced favorable two-year findings from the ARCH study for sevasemten (EDG-5506) in adults diagnosed with Becker muscular dystrophy. Sevasemten, an oral small molecule, aims to deter muscle damage induced by contractions in conditions like Becker and Duchenne muscular dystrophy.
Becker Muscular Dystrophy Overview
Becker Muscular Dystrophy (BMD) is a genetic disorder characterized by progressive muscle weakness and wasting. It primarily affects boys and men, typically manifesting in adolescence or early adulthood. BMD is caused by mutations in the gene that encodes dystrophin, a protein essential for maintaining muscle structure and function.
Get a Free Sample PDF Report to know more about Becker Muscular Dystrophy Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/becker-muscular-dystrophy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Becker Muscular Dystrophy Pipeline Therapeutics Assessment
• Becker Muscular Dystrophy Assessment by Product Type
• Becker Muscular Dystrophy By Stage and Product Type
• Becker Muscular Dystrophy Assessment by Route of Administration
• Becker Muscular Dystrophy By Stage and Route of Administration
• Becker Muscular Dystrophy Assessment by Molecule Type
• Becker Muscular Dystrophy by Stage and Molecule Type
DelveInsight's Becker Muscular Dystrophy Report covers around 8+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Emerging Becker Muscular Dystrophy Drugs Under Different Phases of Clinical Development Include:
• EPM-01: Epirium Bio
• PF1801: ImmunoForge
• Givinostat: Italfarmaco
• Vamorolone: Santhera Pharmaceuticals
• EDG 5506 : Edgewise Therapeutics
Becker Muscular Dystrophy Pipeline Analysis:
The Becker Muscular Dystrophy pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the Becker Muscular Dystrophy treatment with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Becker Muscular Dystrophy Treatment.
• Becker Muscular Dystrophy key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Becker Muscular Dystrophy Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Becker Muscular Dystrophy market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Further Becker Muscular Dystrophy product details are provided in the report. Download the Becker Muscular Dystrophy pipeline report to learn more about the emerging Becker Muscular Dystrophy therapies at:
https://www.delveinsight.com/sample-request/becker-muscular-dystrophy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Becker Muscular Dystrophy Pipeline Market Drivers
• Rising incidence of Becker Muscular Dystrophy
• Improving Healthcare Infrastructure
• Demand for New and Effective Drugs
Becker Muscular Dystrophy Pipeline Market Barriers
• Currently no approved drugs for Becker Muscular Dystrophy in any country
• Very few clinical investigational efforts underway for Becker Muscular Dystrophy
Get a Free Sample PDF Report to know more about Becker Muscular Dystrophy Pipeline Assessment- https://www.delveinsight.com/sample-request/becker-muscular-dystrophy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Scope of Becker Muscular Dystrophy Pipeline Drug Insight
• Coverage: Global
• Key Becker Muscular Dystrophy Companies: Epirium Bio, Immuno Forge, Italfarmaco, Santhera Pharmaceuticals, Edgewise Therapeutics, and others
• Key Becker Muscular Dystrophy Therapies: EPM-01, PF1801, Givinostat, Vamorolone, EDG 5506, and others
• Becker Muscular Dystrophy Therapeutic Assessment: Becker Muscular Dystrophy current marketed and Becker Muscular Dystrophy emerging therapies
• Becker Muscular Dystrophy Market Dynamics: Becker Muscular Dystrophy market drivers and Becker Muscular Dystrophy market barriers
Request for Sample PDF Report for Becker Muscular Dystrophy Pipeline Assessment and clinical trials- https://www.delveinsight.com/sample-request/becker-muscular-dystrophy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1 Becker Muscular Dystrophy Report Introduction
2 Becker Muscular Dystrophy Executive Summary
3 Becker Muscular Dystrophy Overview
4 Becker Muscular Dystrophy- Analytical Perspective In-depth Commercial Assessment
5 Becker Muscular Dystrophy Pipeline Therapeutics
6 Becker Muscular Dystrophy Late Stage Products (Phase II/III)
7 Becker Muscular Dystrophy Mid Stage Products (Phase II)
8 Becker Muscular Dystrophy Early Stage Products (Phase I)
9 Becker Muscular Dystrophy Preclinical Stage Products
10 Becker Muscular Dystrophy Therapeutics Assessment
11 Becker Muscular Dystrophy Inactive Products
12 Company-University Collaborations (Licensing/Partnering) Analysis
13 Becker Muscular Dystrophy Key Companies
14 Becker Muscular Dystrophy Key Products
15 Becker Muscular Dystrophy Unmet Needs
16 Becker Muscular Dystrophy Market Drivers and Barriers
17 Becker Muscular Dystrophy Future Perspectives and Conclusion
18 Becker Muscular Dystrophy Analyst Views
19 Appendix
20 About DelveInsight
Download Sample PDF Report to know more about Becker Muscular Dystrophy drugs and therapies-
Related Reports:
Becker Muscular Dystrophy Market https://www.delveinsight.com/report-store/becker-muscular-dystrophy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Becker Muscular Dystrophy-Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),
Becker Muscular Dystrophy Epidemiology https://www.delveinsight.com/report-store/becker-muscular-dystrophy-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Becker Muscular Dystrophy Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports:
Cerebral Palsy Market
https://www.delveinsight.com/report-store/cerebral-palsy-market
DelveInsight's 'Cerebral Palsy Market Insights, Epidemiology, and Market Forecast 2032' report delivers an in-depth understanding of cerebral palsy, historical and forecasted epidemiology as well as cerebral palsy market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Granulomatosis With Polyangiitis Market
https://www.delveinsight.com/report-store/granulomatosis-with-polyangiitis-market
DelveInsight's "Granulomatosis With Polyangiitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Granulomatosis With Polyangiitis, historical and forecasted epidemiology as well as the Granulomatosis With Polyangiitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Hemophilia A Market
https://www.delveinsight.com/report-store/hemophilia-a2030-market
DelveInsight's "Hemophilia A Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Hemophilia A, historical and forecasted epidemiology as well as the Hemophilia A market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Graft Versus Host Disease Market https://www.delveinsight.com/report-store/graft-versus-host-disease-gvhd-market
DelveInsight's "Graft Versus Host Disease (GvHD) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Graft Versus Host Disease, historical and forecasted epidemiology as well as the Graft Versus Host Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Hemorrhoids Market
https://www.delveinsight.com/report-store/hemorrhoids-market
DelveInsight's "Hemorrhoids Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Hemorrhoids, historical and forecasted epidemiology as well as the Hemorrhoids market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Asthma Market
https://www.delveinsight.com/report-store/asthma-market
DelveInsight's "Asthma - Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Asthma market trends in the United States, EU4 (Germany, France, Italy, Spain), the United Kingdom, and Japan.
Myelodysplastic Syndrome Market
https://www.delveinsight.com/report-store/myelodysplastic-syndrome-market
DelveInsight's "Myelodysplastic Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Myelodysplastic Syndrome, historical and forecasted epidemiology as well as the Myelodysplastic Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Contact Us:
Gaurav Bora
gbora@delveinsight.com
+14699457679
www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Becker Muscular Dystrophy Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight | Epirium Bio, Immuno Forge, Italfarmaco, Santhera Pharmaceuticals, Edgewise Th here
News-ID: 3479600 • Views: …
More Releases from DelveInsight Business Research
DelveInsight Unveils Comprehensive Epidemiology Assessment of Cutaneous Squamous …
DelveInsight, a global leader in healthcare research and analytics, announces the release of its in-depth Cutaneous Squamous Cell Carcinoma (cSCC) Epidemiology Assessment, providing unparalleled insights into the prevalence of cSCC among solid organ transplant recipients across 15 countries, including the United States, key European nations, and select countries in the Asia-Pacific (APAC) region.
The newly released assessment delivers country-specific epidemiological insights aimed at guiding strategic decision-making for pharmaceutical companies, healthcare providers,…
Unlocking Market Potential: DelveInsight's Comprehensive Patent Foramen Ovale (P …
DelveInsight's Market Size & Forecast Assessment Provides Data-Driven Insights for Patient-Centric Market Expansion Strategies
DelveInsight, a leading healthcare market research and consulting firm, has released an in-depth case study highlighting its latest assessment of the Patent Foramen Ovale (PFO) Device Market across the European Union. This strategic market intelligence report provides a holistic understanding of the patient population, device market size, competitor landscape, and reimbursement scenario, equipping medical device companies with…
Global Chronic Obstructive Pulmonary Disease Treatment Devices Market Poised for …
The Chronic Obstructive Pulmonary Disease (COPD) Treatment Devices Market is set for strong expansion, projected to grow at a CAGR of 6.35% from 2025 to 2032, according to recent industry findings. This growth is primarily fueled by the increasing global prevalence of COPD, escalating exposure to tobacco smoke and air pollution, expanding screening programs, and the rapid development of next-generation respiratory devices such as portable nebulizers and smart inhalers.
The global…
CD40 Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA and ROA …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, CD40 pipeline constitutes key companies continuously working towards developing CD40 treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"CD40 Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the CD40 Market.
The CD40 Pipeline report embraces in-depth commercial and…
More Releases for Becker
Robotic Dresspack Market | ABB, Becker, BizLink, Doosan
The global robotic dresspack market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the robotic dresspack market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth of the…
Ultrafine Enamelled Wire Market | Acebsa, DAIKOKU, De Angelli, Ederfil Becker
The global ultrafine enamelled wire market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the ultrafine enamelled wire market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Becker Muscular Dystrophy Market Research Report 2032
DelveInsight's "Becker Muscular Dystrophy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Becker Muscular Dystrophy (BMD), historical and forecasted epidemiology as well as the Becker Muscular Dystrophy (BMD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Becker Muscular Dystrophy (BMD) is an inherited muscle structure disorder that results in progressive deterioration of limbs, cardiac and skeletal muscles. However,…
Becker Muscular Dystrophy - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Becker Muscular Dystrophy - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Becker Muscular Dystrophy - Pipeline Review, H1 2017, provides an overview of the Becker Muscular Dystrophy (Genetic Disorders) pipeline landscape.
Becker muscular dystrophy (BMD) is one of type of muscular dystrophy, a group of genetic,…
Duchenne Muscular Dystrophy and Becker Muscular Dystrophy | Market Research Repo …
Researchmoz added Most up-to-date research on "Frontier Pharma: Duchenne Muscular Dystrophy and Becker Muscular Dystrophy - Identifying and Commercializing First-in-Class Innovation" to its huge collection of research reports.
Highly Innovative and Diverse Pipeline
The Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD) pipeline consists of 84 molecules across all stages of development. GBI Research’s analysis revealed a high degree of innovation and diversity in this indication, with 70% of the pipeline…
CERATIZIT Group acquires German diamond tool manufacturer Becker Diamantwerkzeug …
The CERATIZIT Group has acquired the German company Becker Diamantwerkzeuge on January 9, 2017. Becker produces extremely wear resistant tools for the automotive, mechanical engineering, medical technology, and aerospace industries.
CERATIZIT S.A., Mamer, Luxembourg (headquarters) and Becker Diamantwerkzeuge, Puchheim, Germany, January 9, 2017 - Becker tools are used when it comes to materials that are exotic and difficult to machine, such as aluminum, carbon fiber reinforced plastics or high alloy steel.…
